To examine whether systemic levels of galectin- 3 are increased upon COVID-19, galectin-3 was quantified with an ELISA kit (R&D Systems) in the serum of COVID-19 patients hospitalized at the Evangelismos University Hospital (Table 1 and Figure S1). This evidence concerns the gene LGALS3 and COVID-19.